Thus the childhood reduction of hypoxia-induced ROS accumulation at altitude, by appropriate up-regulation of PDK1 and HPH3, to levels we found in control children, might prevent time induced accumulation of ROS which ultimately may lead to the clinical development of the CMS syndrome in the children fathered by CMS patients. This evidence concerns the gene EGLN3 and congenital myasthenic syndrome.